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Abstract
Background. Renal failure is an increasingly common condition with limited treatment options that is causing a major
financial and emotional burden on the community. Andrographis paniculata is the plant used in Ayurveda for several
remedies. Scientific evidence suggests its versatile biological functions that support its traditional use in the Orient. The
plant is claimed to possess immunological, antibacterial, anti-inflammatory, antithrombotic, and hepatoprotective
properties. But, to date, there is no study demonstrating the protective effect of A. paniculata on gentamicin-induced
renal failure. The present study aims to highlight the first ever reported, antirenal failure activity of A. paniculata.
Methods. Male Wistar albino rats were divided into three groups: normal control, gentamicin control, and aqueous extract of
A. paniculata (200 mg/kg, per oral (p.o.))-treated. The nephrotoxic model was induced by gentamicin (80 mg/kg,
intraperitoneal (i.p.)). Blood samples were examined for serum creatinine, serum urea, and blood urea nitrogen after the 10
days of treatment.
Results. A gentamicin-induced nephrotoxic animal model was successfully prepared. Aqueous extract of A. paniculata
attenuated the gentamicin-induced increase in serum creatinine, serum urea, and blood urea nitrogen levels by 176.92%,
106.27%, and 202.90%, respectively.
Conclusion. The present study reports that the aqueous extract (whole plant) of A. paniculata (Burm. f.) Nees exhibits a
significant renoprotective effect in gentamicin-induced nephrotoxicity in male Wistar albino rats.
Key words: Albino rats, andrographis, aqueous extract, ayurveda, blood urea nitrogen, nephrotoxic, renal failure, serum creatinine,
serum urea, wistar rats
Introduction
Kidney disease is the ninth leading cause of death in
the United States (1). The most recent data suggest
that 27 million individuals have chronic kidney
disease, representing nearly one in every seven adults
and a 30% increase over the past decade (2). More
than 200,000 people in the US suffer from kidney
failure (3). The prevalence of non-terminal renal
failure in Swedish children 1 to 15 years of age was
registered as 4.50 per million total population (4).
This increase is not unique to Sweden; many Asian
countries have also seen a similar increase in the
incidence of end-stage renal failure (ESRF) due to
an increasing incidence of the risk factors for renal
disease (5). Population-sampling studies from
around the globe indicate similar prevalence rates,
usually ranging between 10% and 13% (6). Two
community-based studies, although methodologi-
cally different, have shown a prevalence of chronic
renal failure of 0.16% and 0.79% in India (7). To
date, renal replacement is the only therapy for ESRF.
In case of non-availability of a kidney, dialysis is the
only alternative, which unfortunately is severely
limited by several constraints including a good
amount of expenditure. No exclusive drug has
been reported so far in any category of medical
treatment. The popularity of complementary medi-
cine has increased worldwide. Herbal remedies have
been developed through traditional knowledge of
herbs, which is a ray of hope for kidney failure
patients. A number of herbs, traditionally used, are
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DOI: 10.1080/03009730903174321Phoenix dactylifera (8), Kalanchoe pinnata (9), Ficus
exasperata (10), and Curcumin (11). In continuation
of our work exploring herbal potential for diabetes
(12,13) and antioxidants (14), the present paper
explores the potential of aqueous extract of Andro-
graphis paniculata for significant amelioration of
renal failure in gentamicin-induced nephrotoxic
male Wistar albino rats.
A. paniculata (Burm. f.) Nees (Acanthaceae),
commonly known as ‘kalmegh’ in India, is used as a
bitter ingredient in 26 Ayurvedic formulations as
immunomodulatory (15), antiangiogenic (16), an-
ticancer (17), and in treatment of various liver
disorders (18). However, no attention has been
paid so far to exploring its renoprotective activity
in animals and human beings.
Materials and methods
Plant material
The fresh whole plants of A. paniculata properly
identified and authenticated were obtained from the
National Botanical Research Institute, Lucknow,
India. These were washed, dried, powdered, and
finally stored in air-tight glass jars.
Preparation of extract
The whole plant material (5.0 g) was extracted with
distilled water (100 mL) twice, overnight at 28928C
with continuous stirring. The extract was evaporated
under reduced pressure to a known volume
(100 mL) and was evaporated to dryness at 408C.
The strength of the aqueous root extract was
calculated to be 50 mg/mL.
Animal model
The study was performed on male Wistar albino rats
of approximately the same age-group and body-
weight (23 weeks; 130910 g), housed in ventilated
animal rooms at a temperature of 24928C with a
12 h light/dark cycle and 60%95% humidity. They
were fed with Amrut Laboratory Animal Feed,
manufactured by Nav Maharashtra Chakan Oil
Mills Ltd, Pune, India. Water was provided ad
libitum. All experiments were performed according
to the norms of the local ethical committee.
Experimental protocol
Animals were randomly divided into three groups of
five animals each. Group I was kept as normal
control receiving isotonic saline (0.5 mL, i.p.) for 8
consecutive days, and animals of groups II and III
were administered gentamicin, manufactured by
Wockhardt Ltd, India (80 mg/kg/day, i.p.) for 8
consecutive days, which is well known to produce
significant nephrotoxicity in rats (19). Injections of
gentamicin were made daily at 08:00 hours to
minimize the circadian variation in nephrotoxicity
(20).
Groups I and II received vehicle (0.5 mL gum
acacia, p.o.) for 10 days and group III was orally
administered aqueous extract of A. paniculata sus-
pended in 1% w/v gum acacia at a dose of 200 mg/kg
for 10 days. After the last application, individual rats
were placed in metabolic cages for 24 hours of urine
collection to determine the urine output. At the end
of 24 hours, the rats were anaesthetized with a
combination of ketamine (60 mg/kg) and xylazine
(5 mg/kg) given intraperitoneally. Blood samples
were collected via retro-orbital puncture in plain
plastic tubes, left to stand at 48C for 1 hour, and
centrifuged (900 g for 15 min at 58C) to separate
serum. The serum obtained was stored at 58C
until analysis.
Biochemical analysis
The concentration of creatinine in serum was
measured by Jaffe reaction using a commercial kit
(Human, Germany). The urea level was measured in
serum by using a commercial kit (Beacon Diagnos-
tics, India), and blood urea nitrogen concentration
was measured by using a commercial kit (ERBA
Diagnostics, Germany).
Statistical analysis
All results are expressed as mean9standard error
(SE). Statistical differences between correlated sam-
ples were evaluated using Student’s t test and noted
to be significantly different where PB0.05. Student
t test calculations were assessed on the online
scientific calculators (21). Composite treatments
were compared using one-way analysis of variances
(ANOVA) and considered significantly different
where probability values were found to be equal to
or less than 0.05. All ANOVA tests, as well as mean
and standard error of mean calculations, were
performed using GraphPad Prism (GraphPad Soft-
ware, Inc., San Diego, USA).
Results
Gentamicin (80 mg/kg) when injected for 8
consecutive days caused marked nephrotoxicity
as is evident from Table I, showing significant
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serum urea (121.96%), and blood urea nitrogen
(241.65%) as compared to normal control animals.
These results were supported by 24 h urine output
of individual nephrotoxic rats of group II. The urine
volume of nephrotoxic animals was found to be
significantly (PB0.001) increased (by 106.20%)
when compared to normal control. The aqueous
extract of A. paniculata-treated rats differed from
normal control rats by an elevated concentration of
serum creatinine (20.00%, P 0.05), serum urea
(15.69%, PB0.01), blood urea nitrogen (38.75%,
PB0.0001), and urine volume (15.50%, P 0.05).
No statistical difference could be obtained in serum
creatinine and urine volume, while the levels of
blood urea nitrogen and serum urea were found to
be statistically significantly different as compared to
normal rats. Hence, we conclude that all the para-
meters in the extract-treated group were not iden-
tical but closer to the normal animals. The extent of
protection offered by the test extract was found to be
176.92%, 106.27%, and 202.9% in terms of bio-
chemical parameters, namely serum creatinine,
serum urea, blood urea nitrogen, respectively, and
the 90.70% reduction in urine volume voided also
supports the amelioration of polyuric acute renal
failure by the aqueous extract of A. paniculata.
Discussion
This study strongly suggests that aqueous extract of
A. paniculata exhibits a protective action on genta-
micin-induced acute renal failure. Gentamicin has a
nephrotoxic potential as indicated by the impair-
ment in the renal function, which was reflected in
the significant increases in serum creatinine, serum
urea, and blood urea nitrogen levels when compared
with the normal controls (Table I). It has been
documented that gentamicin-induced nephrotoxi-
city resulting in an increase in serum creatinine,
accompanied by an increase in blood urea nitrogen
levels and severe proximal renal tubular necrosis,
leads to renal failure (22,23). The significant in-
creases in urine output recorded in the present study
also confirm the gentamicin-induced polyuric acute
renal failure.
The effects induced by gentamicin were signifi-
cantly reversed by the aqueous extract of A. panicu-
lata, adding further evidence that this plant has the
potential to be used to ameliorate gentamicin
nephrotoxicity.
Gentamicin administration to rats appears to
enhance the production of O2
 anions and unstable
OH+ radicals. Andrographolide, one of the major
chemical constituents of the plant A. paniculata, has
been reported to possess antioxidant activity (24). It
may be hypothesized that gentamicin treatment is
likely to produce free radicals indicating oxidative
damage at the cellular level of the renal cortex.
Thus, the possible mechanism of renoprotection of
A. paniculata may be attributed to its antioxidant
and free radical-scavenging properties. The exact
mechanism by which A. paniculata extract amelio-
rates gentamicin-induced nephrotoxicity remains to
be elucidated.
In conclusion, the present study explores for the
first time that the aqueous extract of A. paniculata
was able to produce considerable alleviation from
the nephrotoxic action of gentamicin in male albino
rats and hence exhibits marked renoprotective activ-
ity and can be deemed to be a good bioagent for
the treatment of acute renal injury induced by
nephrotoxins. Chromatographic fractionation of dif-
ferent parts of the plant extracted in a series of
organic solvents, followed by characterization of the
Table I. Effect of aqueous extract of Andrographis paniculata (200 mg/kg) on serum creatinine, serum urea, blood urea nitrogen levels and
urine volume in gentamicin-induced nephrotoxic rats.
Groups
Serum creatinine
(mmol/L) Serum urea (mmol/L)
Blood urea nitrogen
(mmol/L) Urine volume (L)
Normal 57.4690.01 5.2591.03 6.8991.40 2.5810
390.11
Gentamicin control
(80 mg/kg, i.p.)
170.6190.30
a (196.92) 11.6490.43
b (121.96) 23.5490.63
b (241.65) 5.3210
390.20
b (106.20)
Extract-treated
(200 mg/kg, p.o.)
68.9590.10
c (20.00) 6.0790.32
d (15.69) 9.5690.16
d (38.75) 2.9810
390.50
c (15.50)
Statistics (one-way
ANOVA)
F15.607 (PB0.001) F44.690 (PB0.001) F42.977 (PB0.001) F23.622 (PB0.001)
Values are mean9SE (n5). Data for normal animals are considered as base-line data; there was no significant base-line difference
between the groups. Percentage increase (in parentheses) is calculated with reference to normal control.
aPB0.01 versus control group.
bPB0.001 versus control group.
cPB0.01 versus gentamicin group.
dPB0.001 versus gentamicin group.
138 P. Singh et al.bioactive principle(s) responsible for the observed
significant renoprotective efficacy of the plant, is in
progress.
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